Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsNorthwestern Medicine investigators have developed a new imaging approach to more accurately assess blood flow in the spinal cord, a method that could be used to better inform treatment for neurological diseases and injuries, ...
Parenting any young child is full of highs and lows. In addition to these, parents and caregivers of children with neurodevelopmental conditions such as autism and attention-deficit hyperactivity disorder (ADHD) are more ...
A new study by researchers from Duke-NUS Medical School has revealed that almost all community-dwelling older adults with advanced dementia in Singapore experience at least one potentially burdensome intervention in their ...
Researchers from Tokyo Metropolitan University have applied ideas from polymer physics to illuminate the mechanism behind a key pathology in Alzheimer's disease, the formation of fibrils of tau proteins. They showed that ...
For individuals who are currently cognitively unimpaired, the lifetime and 10-year absolute risk of mild cognitive impairment (MCI) and dementia increases with increasing amyloid positron emission tomography (PET) centiloid ...
University of Kentucky researchers have developed a new experimental model that could point the way toward more effective Alzheimer's disease treatments by targeting one of the brain's most important genes for risk and resilience.
In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...
1.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
2.
Two-part prodrug system activates immune attack only in tumor's unique environment
3.
The FDA Approves the New Frontline Aggressive ALL Regimen.
4.
La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.
5.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
1.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
2.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
3.
Unlocking the Secrets of Improved Ovarian Cancer Survival Rates
4.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
5.
Deep Learning Fluorescence Imaging for Oral Cancer Surgery: In Silico Depth Quantification
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation